Chong Kun Dang Pharmaceutical Corp.
185750 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185750007
- LEI:
- Country:
- South Korea
- Address:
- 서울 서대문구 충정로3가 3가 368 종근당빌딩, 서대문구
- Website:
- https://www.ckdpharm.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 승인)
|
Korean | 7.2 KB | ||
| 2025-08-22 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 13.5 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 4.9 MB | ||
| 2025-08-01 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-24 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 15.8 KB | ||
| 2025-06-24 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 99.9 KB | ||
| 2025-06-12 00:00 |
Regulatory Filings
유형자산취득결정
|
Korean | 7.9 KB | ||
| 2025-06-12 00:00 |
Regulatory Filings
풍문또는보도에대한해명(미확정)
|
Korean | 8.0 KB | ||
| 2025-06-10 00:00 |
Regulatory Filings
풍문또는보도에대한해명(미확정)
|
Korean | 6.2 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1.8 MB | ||
| 2025-05-22 00:00 |
Regulatory Filings
기타경영사항(자율공시) (CKD510 기술수출 관련 마일스톤 수령)
|
Korean | 5.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.9 MB | ||
| 2025-04-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-23 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (듀비엠폴서방정(CKD383) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 16.9 KB | ||
| 2025-04-23 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (듀비엠파정(CKD398) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 16.6 KB |
Automate Your Workflow. Get a real-time feed of all Chong Kun Dang Pharmaceutical Corp. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Chong Kun Dang Pharmaceutical Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chong Kun Dang Pharmaceutical Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy
SHE
Italy
SHE
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom
STX
United Kingdom
STX
A biotech firm developing stem cell tech, POCT diagnostics, and blockchain platforms.
United States of America
SISI
United States of America
SISI
Develops and sells collagen skincare, health foods, and pharma via a global mail-order model.
Japan
4931
Japan
4931
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea
019170
South Korea
019170
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan
4507
Japan
4507
Develops drugs to enhance radiation therapy for cancer and offers predictive diagnostics.
United States of America
SHPH
United States of America
SHPH
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland
SFZN
Switzerland
SFZN
Develops antiviral drugs for global health security against biothreats and infectious diseases.
United States of America
SIGA
United States of America
SIGA